NR3C1 and inner ear disorder: In this regard, glucocorticoids have been widely used in the therapy of inner ear disease and acute noise-induced hearing loss [45] and since Nr3c1 is a glucocorticoid receptor found in rat, mouse, and human, even during development stage in mouse ears [46–49], DA9801 might involve this valuable endogenous target.